| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V87650 | (R,R)-PCSK9 degrader 1 | 2216703-12-5 | (R,R)-PCSK9 degrader 1 is an isomer of PCSK9 degrader 1. |
|
V98991 | 7030B-C5 | 370871-42-4 | 7030B-C5 is a PCSK9 inhibitor (IC50=1.61 μM). |
|
V128487 | ALD306 | ALD306 is a human monoclonal antibody (mAb) that targets PCSK9. | |
|
V87653 | AZD8233 | 2604215-74-7 | AZD8233 is a liver-targeting antisense oligonucleotide that inhibits proprotein convertase/subtilisin 9 (PCSK9) protein synthesis. |
|
V87655 | AZD8233 sodium | AZD8233 sodium is a liver-targeted antisense oligonucleotide that inhibits proprotein convertase/subtilisin/kexin type 9 (PCSK9) protein synthesis. | |
|
V129726 | AZD8233 sodium scrambled negative control | The AZD8233 sodium scrambled negative control is a negative control with the sequence of AZD8233 sodium salt scrambled. | |
|
V130114 | Bezeparsen sodium scrambled negative control | The Bezeparsen sodium scrambled negative control is a negative control for Bezeparsen sodium with a scrambled sequence. | |
|
V98901 | BRD8518 | 1565828-01-4 | BRD8518 is a PCSK9 inhibitor (EC50=0.23 μM). |
|
V87646 | Cepadacursen sodium | 2252375-14-5 | Cepadacursen sodium is a liver-targeted antisense oligonucleotide that inhibits proprotein convertase/subtilisin/kexin type 9 (PCSK9) protein synthesis. |
|
V131381 | Cepadacursen sodium scrambled negative control | The Cepadacursen sodium scrambled negative control is a negative control with the sequence of Cepadacursen sodium scrambled. | |
|
V87648 | CVI-LM001 | CVI-LM001 is a PCSK9 inhibitor that regulates the level of low-density lipoprotein cholesterol (LDL-C) in the blood by inhibiting the interaction between PCSK9 and low-density lipoprotein receptor (LDLR), thereby exerting a lipid-lowering effect. | |
|
V87324 | DC371739 | 2135765-21-6 | DC371739 is a potent, orally active PCSK9 inhibitor. |
|
V87654 | E28362 | 930017-01-9 | E28362 is a small molecule PCSK9 inhibitor. |
|
V135106 | Enlicitide (decanoate) | 2861205-06-1 | Enlicitide (decanoate) is an orally effective cyclic peptide PCSK9 inhibitor. |
|
V99540 | MeIm | 2043947-71-1 | MeIm (compound 7) is a high-affinity PCSK9-targeting peptide mimetic with cholesterol-lowering activity. |
|
V99859 | PCSK9 allosteric binder-1 | 2215932-06-0 | PCSK9 Allosteric Binder-1 (Example 70) is a PCSK9 allosteric binder. |
|
V142309 | PCSK9 autophagic degrader 2 | 2974497-11-3 | PCSK9 autophagic degrader 2 is a PCSK9-targeted autophagosome with a DC50 of 20.6 nM. |
|
V142310 | PCSK9 Inhibitor, EGF-A | PCSK9 Inhibitor, EGF-A is a PCSK9 inhibitor. | |
|
V87649 | PCSK9-IN-26 | 3033361-09-7 | PCSK9-IN-26 (Compound 116) is a PCSK9 inhibitor (IC50 < 1 nM). |
|
V87651 | PCSK9-IN-27 | PCSK9-IN-27 (Compound 108) is a PCSK9 inhibitor (IC50: 3.4 nM). |